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The phrase “temporomandibular disorders (TMDs)” is a collective term embracing a number of clinical problems that involve the 
masticatory musculature, the temporomandibular 
joint (TMJ) and associated structures, or both. These 
disorders are accompanied by pain in the masticatory 
muscles, in the TMJ, and in the associated hard and 
soft tissues. Other symptoms include limitation or 
deviation in the mandibular range of motion, TMJ 
sounds, and/or headaches and facial pain.1-6 Symp-
toms of TMDs occur in approximately 6 to 12 percent 
of the adult population or approximately ten million 
individuals in the United States.7,8 It is estimated that 
17,800,000 workdays are lost each year for every 
100,000,000 full-time working adults in the United 
States due to disabling TMDs.
The epidemiologic predilection of TMDs in 
women is striking. In the general population, TMDs 
are two times more prevalent in women than in men, 
whereas in patient populations these diseases have 
a female-to-male preponderance as high as 10:1.6,8,9 
Furthermore, unlike similar diseases of other joints, 
which also have a greater female predilection but oc-
cur postmenopausally,10 a large proportion of women 
with TMDs are between eighteen and forty-five years 
of age.11,12 The reasons for this marked sexual dimor-
phism and age distribution remain unclear.
Of the patients with TMDs, approximately 80 
percent present with signs and symptoms of joint 
disease, including disc displacement, arthralgia, 
osteoarthrosis, and osteoarthritis,13,14 indicating that 
an understanding of the underlying pathobiology 
of diseases of the TMJ itself would be beneficial 
to a large proportion of patients with TMDs. These 
degenerative TMJ diseases are characterized by 
an imbalance in the synthesis and degradation of 
matrices, which are mediated by chondrocytes and 
fibrochondrocytes in the cartilage and fibrocartilages 
of the TMJ, resulting in a progressive loss of extra-
cellular matrix components of the articular cartilage 
and/or subchondral bone. Due to a poor understand-
ing of the etiology or pathogenesis of these diseases 
and the lack of definitive diagnostic or therapeutic 
approaches, patients often have to tolerate symptoms, 
including debilitating pain, that substantially impact 
their quality of life over extended periods of time. 
While little is known about the etiology or factors 
that predispose to degenerative diseases of the TMJ, 
recent findings employing both basic biomedicine 
and new imaging and computer technologies are 
beginning to provide important insights that may 
help in deriving rational diagnostic and therapeutic 
strategies. The focus of this review is to provide a ba-
sic foundation on degenerative disorders of the TMJ 
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and to discuss current biomedical and technological 
advances in the understanding of these conditions. 
The implications of these advances for prevention, 
diagnostic, and therapeutic strategies are described. 
Anatomy of the TMJ 
The TMJ is a ginglymoarthroidal joint: that 
is, a joint that is able to have both rotational and 
translational movements. The TMJ is formed by the 
mandibular condyle fitting into the mandibular fossa 
of the temporal bone (Figure 1A). Separating these 
two bones from direct contact is the articular disc. 
The articular portion of the disc is comprised of dense 
fibrous connective tissue devoid of any nerves and 
vessels; conversely, the posterior attachment of the 
disc is richly vascularized and innervated. The disc 
is attached to the condyle both medially and laterally 
by collateral ligaments. Rotational movement occurs 
between the condyle and the inferior surface of the 
disc during early opening (the inferior joint space), 
and translation takes place in the space between 
the superior surface of the disc and the fossa (the 
superior joint space) during later opening. Synovial 
fluid within the joint facilitates movement within the 
joint; it also serves as a medium for the transporta-
tion of nutrients to and waste products from articular 
surfaces.
The mandibular condylar cartilage is com-
prised of four distinct layers or zones (Figure 1B). 
The most superficial layer is called the articular zone 
or superficial zone. It is found adjacent to the joint 
cavity and forms the outermost functional surface. 
This zone is responsible for dissipating shearing and 
frictional loads generated by jaw functions. One way 
it is able to accomplish this is by the expression of 
a protein named superficial zone protein (SZP). In 
the TMJ, SZP localizes to the superficial layer of the 
mandibular condylar cartilage and the TMJ disk.15 
SZP is a large proteoglycan that is synthesized and 
secreted into synovial fluid. It is known to function 
as a boundary lubricant in articular joints by reduc-
ing the coefficient of friction of the mandibular 
condylar cartilage surface and the strain energy of 
the synovial fluid.16 
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Figure 1. Gross anatomy, organization, and histology of the TMJ
A. Skeletal components that make up the TMJ include the glenoid fossa (GF) and articular eminence (AE) of the temporal bone 
(TB), the mandibular condyle (MC), and the intervening articular disc (AD), which are surrounded by the synovial capsule (SC). 
B. Histology of the mandibular condylar cartilage demonstrates four distinct zones: a-articular, b-polymorphic or proliferative, 
c-flattened or chondroblastic, and d-hypertrophic.
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The second zone is the polymorphic or prolif-
erative zone. This zone is mainly cellular with undif-
ferentiated mesenchymal tissue. The cartilage cells 
in this layer are large and enclosed in lacunae. There 
is no organization of formation or arrangement of 
cartilage cells in this layer. This tissue is responsible 
for the proliferation of articular cartilage in response 
to the functional demands placed on the articular 
surfaces during loading and unloading. This zone 
is characterized by the expression of Sox-9 and the 
absence of the expression of Collagen type II.17 The 
third zone is the flattened or chondroblastic zone. 
The cartilage cells in this region are highly mature. 
The cartilage cells have not yet lost their ability to 
proliferate.18 In this zone, the collagen fibrils are ar-
ranged in bundles in a crossing pattern. The cartilage 
appears in a random orientation, providing a three-
dimensional network that offers resistance against 
compressive and lateral forces. Cells in this layer are 
characterized by the expression of Sox-9, Collagen 
types I and II, and Indian hedgehog.17
The fourth and deepest zone is the hypertro-
phic zone. In this zone, the chondrocytes become 
hypertrophic, die, and have their cytoplasm evacu-
ated, forming bone from within the medullary cav-
ity. Cartilage breakdown occurs, and cartilaginous 
spicules undergo calcification with hydroxyapatite 
crystals. The surface of the extracellular matrix 
scaffolding provides an active site for remodeling 
activity as endosteal bone growth proceeds. Deeper 
into the zone, bone and marrow spaces are present. 
The bony trabeculae are arranged randomly and not 
perpendicular to the articulating surface. Cells in this 
zone are characterized by the expression of Indian 
hedgehog, Osteopontin, and Collagen type X.17 
The TMJ disc is an articular disc composed of 
dense fibrous connective tissue, which is primarily 
deficient of any blood vessels or nerve fibers. The 
disc lies in between the condyle of the mandible and 
the mandibular fossa of the temporal bone. The disc 
divides the joint cavity into two distinct components: 
the upper compartment and the lower compartment. 
The upper or superior cavity is delineated by the 
mandibular fossa and the superior surface of the 
disc. The lower or inferior cavity is bordered by 
the mandibular condyle and inferior surface of the 
disc. Each compartment is filled with a plasma-like 
synovial fluid secreted by cells of the synovial lining. 
Synovial fluid serves as a multipurpose substance. 
Since the articular disc and the articular surfaces of 
the joint are devoid in vasculature, the synovial fluid 
acts as a vehicle for providing metabolic require-
ments for these tissues. Also, the synovial fluid aids 
in minimizing friction by serving as a lubricant in 
between all these articular surfaces.19
The morphology of the disc matches the shape 
of the condylar head and the mandibular fossa. In the 
frontal view, the disc is concave inferiorly, designed 
to fit over the condylar head, and concavely superiorly 
to fit the convex surface of the mandibular fossa of the 
temporal bone.20 The articular disc is attached firmly 
to the medial and lateral poles of the condyle in order 
to prevent the disc from excessively moving during 
condylar movements. In the sagittal plane, it can be 
divided into three regions according to thickness. The 
central area is the thinnest; the anterior and posterior 
regions are much thicker in comparison. From the an-
terior view, the disc is thicker medially than laterally. 
The articular disc is attached posteriorly to a region 
of loose connective tissue, known as the retrodiscal 
tissue, which is highly vascularized and innervated.19 
Cells of the TMJ disc are characterized by the expres-
sion of Versican21 and little expression of Collagen 
type II.22 Interestingly, the TMJ disc does not form 
in mice deficient for Indian hedgehog.17
Uniqueness of the TMJ  
The TMJ is different in composition and devel-
opment from other joints in the body. Therefore, it 
is not surprising that there are certain diseases that 
affect every joint in the body except for the TMJ. 
Conversely, it is likely that the unique age and gender 
distribution of TMJ disorders may result from these 
differences between the TMJ and systemic joints. In 
other synovial joints in the body, the articular surfaces 
are covered by hyaline cartilage. The TMJ is different 
because it is composed of fibrocartilage.23 One of 
the unique characteristics of fibrocartilage is that it 
contains both types I and II Collagens, compared to 
articular hyaline cartilage, which only contains type II 
Collagen.24 Fibrocartilage is better able to withstand 
sheer forces than hyaline cartilage can, which makes 
it a superior material for enduring the large amount 
of occlusal load that is placed on the TMJ.25 Other 
advantages of fibrocartilage in the TMJ over hyaline 
cartilage are that the fibers are tightly packed and are 
able to withstand the forces of movement; it is less 
susceptible to the effects of aging; it is less likely 
to break down over time; and it has a better ability 
to repair.26 On the other hand, fibrocartilage may be 
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targeted differently from hyaline cartilage by factors 
such as sex hormones that predispose to degenerative 
changes as discussed below. 
Another difference between the TMJ and other 
joints is that the cartilage of the mandible condyle 
is a secondary cartilage compared to the articular 
cartilage found in other joints, which is a primary 
cartilage.27 More specifically, secondary cartilage 
develops in association with specific bones formed 
by intra-membranous ossification after the bones 
are already formed. This is different from cartilage 
associated with endochondral ossification, where the 
cartilage precedes the bone formation and is referred 
to as a primary cartilage. Primary cartilage growth 
begins in the cartilage cells within the central layer 
of an epiphyseal plate. In this developmental stage, 
the cells undergo mitosis. The two daughter cells 
will contain the total amount of genetic information 
from the original cell. In the next phase of epiphyseal 
growth, the two daughter cells enlarge to the size of 
the original. Each cell produces and secretes extra-
cellular matrix, which causes the cells to drift away 
from each other and to enter various pathways. The 
cells may either become a new progenitor cell or be 
replaced by bone. One of the key elements of primary 
cartilage growth is that growth occurs in the middle 
part of an epiphyseal plate of a long bone. When 
new growth occurs within existing tissue, it is called 
interstitial growth.28,29 
Secondary condylar cartilage growth begins 
with undifferentiated cells comprising mesenchymal 
tissue covering the prenatal or postnatal condyle. In 
the developmental stages, the mesenchymal cells split 
within themselves to become even smaller cells, but 
eventually attain full size. These mesenchymal cells 
then migrate into the interior condyle, and from there 
into the cartilage, where differentiation occurs and the 
cells become immature cartilage cells.29 The growth 
in the cartilage has occurred through differentiation 
of mesenchymal tissue rather than mitosis of carti-
lage progenitor cells. Where growth occurs from the 
exterior, it is known as appositional growth.28
Two developmental defects, Hunter-Thompson 
chondrodysplasia and fibroblast growth factor-re-
ceptor 3 (FGF-R3) achondroplasia, both of which 
afflict systemic load-bearing joints but not the TMJ, 
provide further evidence for the uniqueness of the 
TMJ. Hunter-Thompson chondrodysplasia results 
from a twenty-two-base pair frameshift mutation of 
the cdmp1 gene, and contributes to a complete loss 
of function of the growth factor cartilage-derived 
morphogenetic protein-1 (CDMP1), a member of the 
bone morphogenic protein superfamily. CDMP1 is 
located and expressed in the synovial-lined load-bear-
ing joints during embryological development. This 
protein has high expression levels in the distal parts 
of limbs, suggesting an important role of CDMP1 
in the development of the appendicular skeleton 
and joint morphogenesis.30 Individuals with Hunter-
Thompson chondrodysplasia have dysmorphic joints 
and are usually short in stature, but show no defects 
of the TMJ.30  
FGF-R3 achondroplasia results from a defect 
in cell signaling, with a subsequent reduction of 
chondrocytes in the growth plate. Patients with 
this disorder have a point mutation in arginine or 
glycine in the gene that codes for FGF receptor 3. 
Under normal conditions, FGF-R3 activation inhibits 
cartilage proliferation; however, the mutation in this 
gene causes a gain of function of this FGF receptor, 
causing the receptor to be in constant activation. 
Phenotypically, the genetic disorder is expressed as 
shortened proximal extremities and an enlarged head 
with bulging forehead and depression of the root of 
the nose.31 Interestingly once again, although most 
other joints in the body are affected by this point 
mutation, the TMJ condylar cartilage does not seem 
to be affected.32 
As outlined above, even though not fully char-
acterized, the TMJ demonstrates specific organiza-
tional, anatomic, and developmental differences from 
other joints. Therefore, broad assumptions derived 
from knowledge about articular hyaline cartilage to 
explain or find appropriate treatments for TMJ dis-
orders are not generally justified. The implications 
of these differences between the TMJ and systemic 
joints are likely to have implications for the causation, 
predisposition to, or progression of TMJ diseases and 
require further study. 
Pathogenesis of 
Degenerative TMJ Diseases
Degenerative diseases of the TMJ occur from 
the loss in equilibrium of anabolic and catabolic pro-
cesses involving chondrocyte initiation, proliferation, 
differentiation, and matrix synthesis and degradation. 
It is characterized by increased degradation of the 
components of the extracellular matrix and is usually 
preceded or accompanied by enhanced levels of in-
flammatory mediators. The initial signs of degenera-
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tive TMJ disease may be sub-clinical; consequently, 
onset of symptoms may not present until later stages 
of development of the disease. While the causes or 
contributing factors for degenerative TMJ disease 
remain largely speculative, three main etiologies have 
been proposed in the literature on the pathogenesis 
of these diseases: altered mechanical loading, female 
hormones, and alterations in the extracellular matrix. 
It is plausible that any one of these alone or in concert 
may predispose any given individual to degenerative 
changes in the joint. Findings from such studies are 
likely to help define novel diagnostic and treatment 
strategies. 
Trauma and/or Aberrant 
Mechanical Loading
One of the possible etiologies of TMJ degen-
erative disease is aberrant mechanical loading by 
either trauma or altered masticatory function. Most 
dentists and physicians have been inclined to believe 
that the single most important etiological factor for 
degenerative TMJ disease is altered mechanical 
loading that surpasses the adaptive capacity of the 
joint.25,33 Studies in mice, rats, rabbits, and non-hu-
man primates have shown that normal masticatory 
function is important for maintaining normal growth, 
morphology, and function of the cartilage of the TMJ. 
In order to examine the effects of altered masticatory 
function on the TMJ in rodents, investigators have 
manipulated the masticatory sequence, which can be 
classified into two stages: incision and chewing.34
Trimming the incisors out of occlusion (be-
lieved to decrease the occlusal force during the inci-
sion stage and decrease the amount of protrusion 
that occurs during the incision stage35,36), replacing 
the standard hard pellet diet with a mushy soft diet 
(believed to decrease the amount of molar force 
required during the chewing stage35,36), or a combina-
tion of the two are all methods used to manipulate 
the masticatory sequence. Altering masticatory load-
ing by the administration of soft diet and/or incisor 
clipping in rodents causes structural changes within 
the mandibular condylar cartilage and subchondral 
bone. In the mandibular condylar cartilage, altering 
the TMJ masticatory loading causes a decrease in the 
thickness of the mandibular condylar cartilage,37-39 
a reduction in the expression of extracellular matrix 
proteins in the cartilage,40 and a reduction of chon-
drocyte proliferation.36,41,42 In the subchondral bone, 
we have recently found that incisor trimming and 
soft diet administration cause a transient decrease 
in the bone volume and trabecular thickness of the 
mandibular condylar subchondral bone for two to 
four weeks, which were restored to normal levels 
over four to six weeks (Wadhwa et al., submitted for 
publication). We believe that these changes in the 
subchondral bone by altered TMJ masticatory loading 
are consistent with changes in the subchondral bone 
reported for TMJ osteoarthritis. 
Traumatic injuries are also an important etio-
logical factor in the development of TMJ disorders. 
One study examining 400 consecutive TMD clini-
cal patients found that, in 24.5 percent of patients, 
the onset of the pain could be linked directly to the 
trauma.43 Individuals who have been in automobile 
accidents and sustained whiplash injuries seem es-
pecially prone to develop TMDs. In recent studies, it 
has been shown that there is an increase in developing 
reduced or painful jaw movements immediately after 
whiplash injury44 and that one in three people who are 
exposed to whiplash trauma are at risk of developing 
delayed TMJ symptoms.45
Hormonal Pathogenesis
Because of the high prevalence of TMDs in 
women of reproductive age,27 it has been postulated 
that sex-based determinants, such as hormonal in-
fluences from estrogen, progesterone, and relaxin, 
may make an individual susceptible to degenerative 
TMJ diseases. Several lines of evidence support this 
hypothesis. Both estrogen and progesterone recep-
tors have been localized in the TMJ of human and 
non-human primates,46-48 in male rats,49 and in mice 
of both genders,50 with some findings suggesting 
a sexual dimorphism in the presence of estrogen 
receptors.47 Other evidence that estrogen is involved 
in TMDs includes an association between facial pain 
and estrogen replacement therapy or the use of oral 
contraceptives51,52 and elevated systemic levels of 
estrogen in women with TMJ disease versus those in 
normal controls.53 In addition, polymorphisms in the 
estrogen receptor have been shown to be correlated 
to the intensity of pain,54 facial axis angle,55 and 
mandibular body length55 in patients who suffer from 
TMJ osteoarthritis. However, despite these studies, 
until recently no direct evidence has been found that 
links female reproductive hormones to TMJ disease 
or that defines the mechanisms by which these hor-
mones may cause TMJ disease. 
Recent findings by our group demonstrate that 
estrogen and relaxin may contribute to TMJ degenera-
tion by enhancing the expression of tissue-degrading 
August 2008 ■ Journal of Dental Education 935
enzymes belonging to the matrix metalloproteinase 
(MMP) family from TMJ fibrocartilage. MMPs 
can degrade the major matrix macromolecules of 
cartilage (namely, collagen and proteoglycans), as 
well as most of the minor proteins in this tissue. Our 
studies show that relaxin and/or estrogen induce 
specific MMPs—namely, MMP-1 (collagenase-1), 
MMP-3 (stromelysin-1), MMP-9 (92 kDa gelatin-
ase), and MMP-13 (collagenase-3)—in mice and/or 
rabbit TMJ disc fibrochondrocytes,56-58 suggesting a 
plausible role of these enzymes in hormone-medi-
ated joint degeneration. Interestingly, the key matrix 
substrates for MMP-1 and MMP-13 are fibrilar 
collagens, including types I and II collagens, and 
those for MMP-3 and MMP-9 are proteoglycans,59,60 
which together comprise the largest proportion of the 
matrix molecules of fibrocartilage. Indeed, we have 
shown that the modulation of MMPs by relaxin and 
estrogen are paralleled by changes in the predomi-
nant matrix molecules collagens and proteoglycans 
in TMJ disc fibrocartilage in vitro and in vivo57,61 
(Figure 2), suggesting a potential relationship be-
tween hormone-modulated MMPs and extracellular 
matrix homeostasis or degradation. Because matrix 
degradation by MMPs is considered to be a primary 
event in the initiation and progression of joint disease, 
this hormone-mediated loss in matrices likely affects 
the ability of the joint to sustain normal function and 
can lead to progressive degenerative changes in the 
joint. These findings, together with the elevated levels 
of estrogen in women with TMJ disease,52 suggest a 
potential role of specific sex hormones in causing or 
predisposing to TMJ degeneration. 
Genetic Basis for Altered Joint 
Extracellular Matrix
Another possible mechanism by which de-
generative diseases of the TMJ may arise is from 
alterations in the extracellular matrix, caused directly 
from genetic perturbations or indirectly from factors 
or hormones (as described above) that influence the 
composition and/or turnover of the extracellular 
matrix of the TMJ. Alterations in the extracellular 
matrix as a possible mechanism behind degenerative 
TMJ diseases are supported by studies in transgenic 
mice that have defects in the extracellular matrix and 
develop TMJ osteoarthritis. To date, three mouse 
models with defects in the extracellular matrix of 
the mandibular condylar cartilage have been shown 
to develop TMJ osteoarthritis.62-64 In one of these 
models, termed Del1, the transgenic mice produce a 
mutated form of the human type II collagen (Col2A1) 
gene driven by the human collagen type II promoter, 
resulting in the mutant protein being expressed solely 
in cartilage.62 Mice with this mutation develop sub-
chondral cysts in the mandibular condyle and clefting 
at three months, and by fifteen months the mandibular 
condylar cartilage was almost completely resorbed. 
The authors hypothesize that the osteoarthritic lesions 
are due to a decreased repair response and by changes 
in the tissue’s micro-architecture, which cause them 
not to be able to withstand the strain and loading as 
well as wild-type controls.
Figure 2
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Figure 2. Relaxin with or without estrogen decreases 
the proteoglycan content of TMJ disc fibrocartilage
TMJ discs cultured in control medium (Ct) or in the pres-
ence of relaxin (R) or estrogen plus relaxin (E+R) were 
stained for proteoglycans (stained red), a major matrix 
molecule in the disc. Discs cultured with relaxin or estro-
gen plus relaxin showed approximately 50 percent reduc-
tion in proteoglycan content. 
Data from: Naqvi T, Duong TT, Hashem G, Shiga M, Zhang 
Q, Kapila S. Relaxin’s induction of metalloproteinases is as-
sociated with the loss of collagen and glycosaminoglycans in 
synovial joint fibrocartilaginous explants. Arthritis Res Ther 
2005;7:R1–11.
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The second mouse model of TMJ osteoarthritis 
has a loss of function mutation in the gene encoding 
the alpha-1 chain of type XI collagen of cho (chon-
drodysplasia) mice.65 At three months, heterozygote 
cho mice show evidence of osteoarthritic changes 
in proteoglycan staining in the superficial articular 
layer of the mandibular condylar cartilage. By nine 
months of age, fibrillations extend across the entire 
surface of the mandibular articular cartilage. The 
observations suggest that the loss of proteoglycan 
in the TMJ cartilage of the cho-deficient mice leads 
to increased exposure of the chondrocytes with type 
II collagen fibrils. The chondrocyte-type II collagen 
fibril interaction in the TMJ leads to signaling through 
the discoidin domain receptor, DDR2, which induces 
the activity and expression of MMP-13 contributing 
to extracellular matrix cartilage degradation.63 
The third TMJ-osteoarthritis mouse model in-
volves deficiencies in the production of two extracel-
lular matrix proteoglycans: biglycan and fibromodu-
lin. At six months of age, osteoarthritic changes first 
begin to develop in the TMJ and progressively get 
worse, and by eighteen months, the double-deficient 
mice have almost complete destruction of the TMJ 
(Figure 3). Biglycan is a small proteoglycan abun-
dant in cartilage, bone, and other connective tissues 
WT
WT
DKO
DKO
500 µm 500 µm
125 µm 125 µm
 A                                      B
C                                       D
Figure 3
Figure 3. Sections of the TMJ from nine-month-old wild type (WT) (A and C) and biglycan/fibromodulin double knock-
out (DKO) mice (B and D) stained with hematoxylin and eosin
The arrowheads show vertical clefts, the asterisks show the small acellular areas under the articular surfaces, and the arrow 
shows regions where chondrocytes lose their regular columnar organization and form clusters.
Reprinted with permission from Wadhwa S, Embree MC, Kilts T, Young MF, Ameye LG. Accelerated osteoarthritis in the temporoman-
dibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthritis Cartilage 2005;13:817–27.
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whose function is not yet understood. Fibromodulin 
is a collagen-binding protein that is homologous to 
biglycan structurally, lending support to the idea that 
both proteoglycans arose from the same ancestral 
gene. Fibromodulin was isolated from cartilage and is 
present in many types of connective tissue, including 
cartilage, tendon, skin, sclera, and the cornea. These 
proteoglycans have several properties that are impor-
tant in the resiliency of articular cartilage. They aid in 
providing water for surface lubrication, are associated 
with collagen, and may aid in directing the formation 
and spatial orientation of the collagen fibrils.
Although the exact mechanism of TMJ os-
teoarthritis is unknown, the absence of biglycan/ 
fibromodulin may cause changes in the extracellular 
collagen network, making the joint less susceptible to 
withstanding mechanical loading and subsequently 
more prone to osteoarthritic lesions.64 In support of 
this notion, it has been observed that, in the knee 
of double-knockout biglycan/fibromodulin mice, 
increased mechanical loading by forced treadmill 
running caused an increased severity of osteoarthritis 
in the knee.66 Another explanation is that changes 
in the TMJ fibrocartilage arise from the ability of 
biglycan/fibromodulin to modulate members of the 
transforming growth factor (TGF)-β superfamily. The 
binding of biglycan and fibromodulin to members of 
the TGF-β family may regulate their activity by se-
questering them into the extracellular matrix, thereby 
preventing their binding with the cellular receptors. 
Evidence has been shown by examination of another 
small leucine-repeat, proteoglycan-deficient mouse 
in which bone marrow stromal cells from biglycan/
decorin double-deficient mice showed an increase in 
TGF-β activity.67   
Although these animal models point towards 
the intriguing possibility for a genetic basis of degen-
erative TMJ diseases, there is currently no evidence 
for these factors in the human disease. However, it 
is possible that future studies will uncover such links 
between genetic defects in the extracellular matrix 
and TMJ disorders, which may provide a basis for 
identifying individuals who have a predisposition to 
the diseases. 
Rational Diagnostics and 
Therapeutics
The recent progress in understanding the bio-
medical basis for TMJ disorders discussed above, 
as well as in computer and imaging technologies, is 
beginning to provide novel insights into the patho-
genesis of degenerative TMJ diseases and point to-
wards the possible use of this knowledge in devising 
rational diagnostic and therapeutic strategies. Some 
of the likely uses of these approaches in diagnosis, 
prognostics, and therapeutics are outlined below. 
Imaging
Several methods are available for imaging 
the TMJ. These include basic radiography (such as 
panorexes and corrected tomograms), ultrasonog-
raphy, magnetic resonance imaging, and spiral or 
conebeam computed tomography. The latter tech-
nologies allow the joint to be visualized as sections 
in different planes and can also be rendered as 3D 
volumetric reconstructions to enhance diagnostic 
capabilities (Figure 4). Magnetic resonance imaging 
and ultrasonography have the added advantage over 
CT scans in that they enable soft tissues such as the 
disc, ligaments, and muscles to be visualized and may 
be more useful than CTs when the patient presents 
with internal derangement or joint dysfunction.68,69 
With currently available software, which is relatively 
user-friendly, the raw DICOM files obtained from 
MRI or CT scans can be compiled, manipulated, and 
visualized by the clinician in the office. 
The introduction of the conebeam CT (CBCT) 
systems specifically designed for use in dentistry has 
opened up new opportunities for deriving additional 
diagnostic information (Figure 4). Although CT 
scans and MRI have been available for many years, 
several barriers have precluded their widespread use 
in evaluating TMJ disorders. These include high cost, 
radiation exposure (in the case of CT scans), and, to 
a lesser extent, difficulty accessing units, most of 
which are located in hospitals and medical imaging 
laboratories. The introduction of CBCT units that are 
now available in dental schools, dental X-ray labo-
ratories, and even private practices has eliminated 
some of these barriers to the use of advanced imaging 
technology, when indicated in specific cases.
One key issue in CBCT imaging involves its 
reliability and diagnostic capabilities relative to the 
spiral CT and conventional tomography. This ques-
tion has been assessed by several investigators.70-72 In 
studies comparing spiral CT and CBCT, no signifi-
cant differences were observed in findings of osseous 
abnormalities.72 The specificity of the condyle assess-
ment was 1.0 with both CBCT and spiral CT, and 
the sensitivity was 0.8 and 0.7 for these two imaging 
modalities, respectively. The investigators concluded 
that 3D images rendered by CBCT are a dose-effec-
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Figure 4. New opportunities for additional diagnostic information available with conebeam CT systems
Conebeam computed tomographic images can be manipulated to derive three-dimensional volumetric images that can be 
viewed from any perspective with superimposing tissues dissected out to clearly visualize the region of interest (A to D) or sec-
tions of desired thicknesses derived in any plane of interest—in this case, axial (E), coronal (F), and sagittal (G) views of the TMJ. 
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tive and cost-effective alternative to spiral CT for the 
diagnostic evaluation of osseous mandibular condyle 
abnormalities. Additional studies on the accuracy of 
linear measurements in CBCT-derived, multiplanar-
reformatted projections for the TMJ compared to 
anatomical measures of skulls and in cephalograms 
showed high accuracy of these measurements on the 
CBCT, but not on the lateral or PA cephalograms.73 
Additionally, the intraobserver measurements on 
the CBCT reconstructions were highly reliable rela-
tive to the anatomic truth, and significantly more so 
than those from the cephalograms. These findings 
together provide support for the utility of CBCT 
imaging for both diagnostic and research purposes 
in TMJ disorders. 
The possible use of CBCT imaging technology 
has been tested for various applications in TMJ disor-
ders. This includes its use in image-guided access to 
the superior joint space for arthroscopic examination 
and treatment of individuals with disc perforations or 
adhesions.74 This technique may improve the safety 
of arthroscopic procedures by decreasing the prob-
ability of inadvertent puncturing of the glenoid fossa 
into the middle cranial fossa. Future modifications 
to 3D-imaging methodologies are likely to involve 
techniques that enhance the sensitivity and specific-
ity of these techniques. In one such approach, we 
determined whether the histopathologic severity of 
TMJ inflammation in an animal model of arthritis 
correlated with quantitative changes over time in the 
MRI signal from a macromolecular contrast agent, 
GdDTPA
30
.75 The arthritic TMJs showed marked 
enhancement of the synovial and subsynovial tis-
sues, which had strong positive relationships with 
all histologic parameters of arthritis, indicating its 
utility for assessing the severity of joint inflammation 
(Figure 5). This or similar techniques may be useful 
for increased sensitivity and specificity of diagnosis, 
and as an aid in the noninvasive monitoring of disease 
severity and treatment response in arthritis. Finally, 
as discussed below, 3D images derived from these 
technologies are likely to become an important and 
integral part of bioengineering custom TMJs for 
subjects in irreversible stages of joint disease. 
Biomedical Approaches to 
Diagnose, Alleviate, or Prevent 
Joint Degeneration
Systemic and Local Biomarkers of Disease. 
Biomarkers of diseases are a highly sought after 
approach for the early diagnosis of various condi-
tions and for evaluating the efficacy of treatment 
modalities. Various sources of samples are used for 
the assaying of disease biomarkers. In the case of 
joint disorders, these samples have included synovial 
lavages or aspirates, tissue samples, serum or plasma, 
or urine. The most common sample used in studies 
performed to date is synovial lavages to determine 
the changes in various local biological mediators of 
disease that may be used subsequently in predicting 
the status of the disease. Findings from such studies 
have demonstrated increased levels of inflammatory 
mediators,76-78 MMPs,77,79-82 and aggrecanase80,83 in 
patients with TMJ disorders versus controls. While 
the synovial lavage or aspirate samples are typically 
obtainable from subjects undergoing arthrocentesis, 
their availability for routine diagnostics is question-
able because of the invasive nature of the procedure. 
Also, inherent limitations in the methodology, includ-
ing unknown dilution effects, make it difficult to 
compare data between subjects and over time84 and 
diminish the utility of this approach for diagnostic 
purposes. 
Synovial tissues from patients with TMJ 
disorders are also a source for evaluating potential 
biomarkers. Investigators using these samples have 
shown that there is increased expression of Il-885 and 
microvessel density86 in TMD patients. However, 
similar to synovial fluid, the invasiveness of the 
procedure to obtain samples makes the evaluation 
of synovial tissues less than ideal. A less invasive 
sampling involves assays on urine or serum. As-
says on urine samples have shown elevated levels 
of pyridinoline (Pyr) and deoxypyridinoline (Dpyr) 
collagen cross-links, which are known markers of 
bone and cartilage turnover, in patients with osteo-
arthritis of the TMJ.87 Additionally, elevated amino 
acid secretion products were found in the urine of 
patients with chronic muscle pain TMD.88 Similarly, 
preliminary studies using serum have suggested 
increased estrogen levels53,89 in TMD patients and 
increased levels of interleukin-1beta and C-reactive 
protein in arthritic TMJ diseases.90 No studies have 
been done to assay for potential biomarkers of TMJ 
disorders using saliva, which would be a highly de-
sirable source for assaying biomarkers for disease or 
therapeutic outcomes. Also, while the studies cited 
above provide insights into potential biomarkers of 
TMJ diseases, much work remains to be done to 
demonstrate the specificity and sensitivity of any 
given marker of the disease status. 
While a “gold standard” biomarker for TMJ 
disorders remains elusive, powerful new technologies 
940 Journal of Dental Education ■ Volume 72, Number 8
such as microarrays on tissue, synovial fluid, or serum 
samples may enable the identification of specific and 
sensitive biomarkers of TMJ disease in the future. 
Microarrays permit the analysis of the expression of 
thousands of genes even with extremely small quan-
tities of sample. Therefore, the use of microarrays 
on blood samples from patients with TMJ disorders 
may be able to identify novel genes or combination 
of genes that are predictive of TMDs. In a recent 
study,91 microarray analysis of 3,543 genes in blood 
samples in patients with mild knee osteoarthritis 
and non-symptomatic controls revealed nine genes 
considered to be predictive of knee osteoarthritis. 
These nine genes were then used to blindly evaluate a 
new sample of sixty-seven subjects and demonstrated 
72 percent sensitivity and 66 percent specificity as 
a test for osteoarthritis. In the next few years, it is 
likely that tests based on findings from such studies 
will become commercially available as viable tools 
to aid the clinician in the early and specific diagnosis 
Control
A B
Arthritic
C D
E F
Figure 5
Figure 5. A macromolecular contrast agent, albumin-(Gd-DTPA)30 in conjunction with dynamic MRIs provides quan-
titative and sensitive data on the magnitude of vascular permeability and extravasation that correlates very highly with 
the severity of joint inflammation
The upper panel demonstrates precontrast (A) and 30-minute postcontrast (B) coronal section of MR images from a control 
rabbit with no joint inflammation. The postcontrast image shows the expected enhancement of blood vessels (BV), the cavern-
ous sinus (CS), and other vascular structures, but only minimal enhancement in the synovium of the TMJs (arrowheads). On 
the other hand, rabbits with TMJ inflammation showed a gradual increase in enhancement of the inflamed synovium from the 
precontrast time point (C) to 2 (D), 10 (E), and 30 (F) minutes after intravenous administration of the contrast agent (depicted by 
arrows and arrowheads). The histologic total arthritic score was highly correlated to the rate of tissue enhancement. R=rami of 
mandible; B=brain; C=condylar heads; M=masseter muscle; R=right.
Reprinted with permission from van Dijke CF, Kirk BA, Peterfy CG, Genant HK, Brasch RC, Kapila S. Arthritic temporomandibular joint: 
correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings. Radiology 1997;204:825–32.
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of various joint disorders, including those involving 
the TMJ. Studies such as these are also likely to help 
identify key pathways and bioactive molecules that 
contribute to the perpetuation of the disease that can 
be targeted for rational therapeutics. 
Genotyping to Identify Subjects at Risk. 
Genetic factors may play a role in determining which 
individuals are more prone to develop TMJ disorders 
or in predicting the severity of the disease process. 
Although recent evidence points to the contrary, TMJ 
disorders traditionally have been believed to have no 
heritability. The support for TMJ diseases not having 
a genetic component is provided by studies showing 
that the incidence and severity of these disorders 
were not different in monozygotic twins compared 
to dizygotic twins.92 If TMJ disorders had a heritable 
component, one would expect an increase in the in-
cidence of the disease in monozygotic twins that are 
genetically identical compared to dizygotic twins that 
are not genetically identical. In contrast, recent stud-
ies have shown that polymorphisms in the serotonin 
transporter gene93 and adrenergic receptor beta gene 
294 cause an increase in the likelihood of developing 
TMJ disorders. Also, polymorphism in the estrogen 
receptor gene causes an increase in pain susceptibility 
in patients with TMJ osteoarthritis.54 The differences 
in findings between studies on the heritability of TMJ 
disorders may have resulted from the inclusion of the 
many different subtypes of the diseases with some 
having a greater genetic component while others have 
minimal or no genetic basis.
Recently, significant resources have been di-
rected towards high-throughput genome sequencing, 
and it seems highly likely that in the next ten to twenty 
years health professionals will have their patients’ 
genomes available for analysis. This diagnostic tool, 
coupled with advances in understanding the genes 
that contribute or predispose to TMJ disorders, may 
make it possible to identify patients who are at risk 
for developing TMJ disorders and enable the imple-
mentation of strategies to prevent the disease.
Using Technology and Biomedicine 
to Engineer the TMJ 
For many people suffering from severe and 
painful degenerative diseases of the TMJ, surgical 
replacement of the mandibular condyle remains the 
only option. Until recently, the primary methods em-
ployed to reconstruct the TMJ included autogenous 
tissue grafting, for example from the rib, or the use of 
alloplastic materials, with neither being ideally suited 
for the task and sometimes leading to extremely 
deleterious effects.95,96 Fortunately, due to recent 
advances in the understanding of stem cell biology 
and biomaterials, it seems that in the near future it 
may be possible to successfully reconstruct a bioen-
gineered TMJ replacement that is compatible with a 
host, biologically viable, and capable of withstanding 
the physiologic loads required of this joint. 
Tissue engineering involves developing in vitro 
and/or in vivo a biological replacement that mimics 
the biological, morphological, and organizational 
characteristics of the tissue it is replacing. The most 
common method for deriving engineered tissues 
involves the implantation of cells, typically derived 
from the host, into a biomimetic scaffold and then 
stimulating it in a bioreactor or in vivo with appropri-
ate signals to derive a replacement tissue or organ.97,98 
Cells from various sources, including articular carti-
lage cells, fibroblasts, human umbilical cord matrix 
stem cells, and mesenchymal stem cells, have been 
used in efforts to reconstruct the TMJ.99,100 Of these 
cells, stem cells have gained increasing prominence in 
the tissue engineering of joints and have been used by 
various investigators for developing prototype TMJ 
condyles. Unlike primary cells such as chondrocytes 
that have limited capacity to propagate, stem cells 
have the additional advantage of being stimulated 
by specific biological cues into differentiating into 
osteoblasts, chondrocytes, fibroblasts, and myocytes 
(Figure 6). These cell types, in turn, generate carti-
lage, bone, ligaments, and muscles, respectively, to 
derive all key components of the TMJ complex. Thus, 
for example, in recent studies101,102 rat bone marrow 
mesenchymal stem cells were grown separately in 
chondrogenic differentiation media or in osteoblastic 
differentiation media. Subsequent transfer of the two 
cell populations into a scaffold with two stratified and 
integrated layers, and then implantation into the backs 
of immunodeficient mice for twelve weeks, resulted 
in a structure containing both cartilage and bone 
tissue in a construct of the shape and dimensions of 
human mandibular condyle. 
Regardless of the source, cells require appropri-
ate stimuli and materials or scaffold into which to be 
seeded in order to differentiate and express bone and 
cartilage matrices into suitable structural organiza-
tion and anatomy of the TMJ. For this purpose, 3D 
imaging technologies can be used to design the scaf-
fold of the same shape and size required at the defect 
site. Indeed, this use of image-based design coupled 
with solid free-form fabrication has been used to gen-
erate biomimetic scaffolds that are both load-bearing 
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and match the defect site geometry100,103 (Figure 7). 
Further improvements in this approach have been 
used to generate Poly-l-lactic acid/hydroxyapatite 
composite biphasic composite scaffolds that, when 
seeded with chondrocytes as well as appropriately 
stimulated fibroblasts, respectively, resulted in the 
expression of cartilage and bone in discrete regions 
with a stable interface between cartilage and sub-
chondral bone (Figure 8). Such approaches to TMJ 
tissue engineering provide site-specific anatomical 
configuration as well as autologous tissues that have 
the potential ability to adapt to the loading forces 
placed on it during function, and hold great promise 
for patients needing joint replacements.
Conclusions
As with other areas of medicine and dentistry, 
advances in biomedicine and computer-based tech-
nologies offer great promise for helping patients 
predisposed to or suffering from TMJ diseases. These 
technologies will enhance diagnostic capabilities 
and rational therapeutics or preventive strategies. 
Figure 6
Figure 6. Mesenchymal stem cells can be stimulated to undergo differentiation into different cell lineages, including 
muscle, bone, cartilage, and ligament, which can be used to derive the entire TMJ complex
Commitment to a particular lineage is driven by the presence of local morphogenic factors. Lineage-committed cells progress 
through a number of transitory stages. Once differentiation is initiated, proliferation is down regulated, and tissue-specific 
proteins are expressed to generate the specific tissue. It is thought that mesenchymal stem cells are present in all organs of the 
body, where they serve to maintain tissue homeostasis.
Reprinted with permission from Risbud MV, Shapiro IM. Stem cells in craniofacial and dental tissue engineering. Orthod Craniofac Res 
2005;8:54–9.
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Figure 7
Figure 8
Figure 7. Image-based design enables the construction of scaffolds that are defect site-specific
The image of the patient or animal condyle (A) is used to generate a computer microarchitecture structure of the desired implant 
design (B), which is used in turn to construct a solid free-form fabrication of the desired material or materials (C). Subsequently, 
the scaffold is seeded with cells and stimulated appropriately to generate bone and cartilage.
Reprinted with permission from Schek RM, Taboas JM, Hollister SJ, Krebsbach PH. Tissue engineering osteochondral implants for tem-
poromandibular joint repair. Orthod Craniofac Res 2005;8:313–9.
Figure 8. Composite scaffolds, shaped as the TMJ condyle, seeded with cells, and appropriately stimulated, generate 
osteochondral tissues mimicking the shape of the condyle 
(A) Safranin-O and fast green staining shows pink-stained cartilage (arrows) in the condylar head in contact with the green-
brown stained bone. (B) Hematoxylin and esoin staining of the hyaluronic acid portion of the scaffold shows the formation of 
bone (arrows) with marrow space.
Reprinted with permission from Schek RM, Taboas JM, Hollister SJ, Krebsbach PH. Tissue engineering osteochondral implants for tem-
poromandibular joint repair. Orthod Craniofac Res 2005;8:313–9.
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Genetic analysis, biomarkers, imaging, and tissue 
engineering will likely expand the repertoire and 
improve the specificity of diagnostic and therapeu-
tic approaches for diseases of the TMJ. Progress in 
biomedicine, imaging, and computer technology also 
point to the need for academicians, researchers, and 
the health care community to appropriately educate 
and prepare future clinicians to take advantage of 
these innovations. 
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